SGBI

Sangui BioTech International, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 5/18/2017
Contact Info
  • Alfred Herrhausen Street 44
  • Witten 58455
  • Germany

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001104280
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: CO, USA
Year of Inc. 1997
Employees 1 a/o May 17, 2017
Company Officers/Contacts
Thomas Striepe CEO
Company Directors
Hubertus Schmelz
Thomas Striepe
Service Providers
Accounting/Auditing Firm
Sadler, Gibb & Associates, LLC
2455 E. Parleys Way
Suite 320
Salt Lake City, UT, 84109
United States
 
Securities Counsel
Chachas Law Group P.C.
11682 El Camino Real.
Suite 100
San Diego, CA, 92130
United States
 
Investor Relations Firm
Fleing Kommunikation
Am Vogelherd 43
Marburg, 35043
Germany
 
Company History
  • Formerly=Citadel Investments Systems, Inc. until 8-97
SGBI Security Details
Share Structure
Market Value1 $5,731,327 a/o Jun 28, 2017
Authorized Shares 250,000,000 a/o Jun 28, 2017
Outstanding Shares 184,881,503 a/o Jun 28, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 167,483,902 a/o May 17, 2017
Par Value No Par Value
Transfer Agent(s) Verified by Transfer Agent
Corporate Stock Transfer, Inc.
Shareholders
Shareholders of Record 876 a/o May 17, 2017
Short Selling Data
Short Interest 44 (0%)
Jun 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security